Moreover, the cooperative function of Bcl‐2 and Mcl‐1 has been identified as a mechanism leading to treatment failure in acute myeloid leukemia (AML), where dual inhibition of these proteins has shown potential to improve treatment results.12 This evidence concerns the gene BCL2 and acute myeloid leukemia.